Clinical trials for Cancer in United States

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

Study ID: NCT06651957

Sponsor

University of California, San Francisco

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Study ID: NCT04199026

Sponsor

M.D. Anderson Cancer Center

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Study ID: NCT06398457

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Genomic Services Research Program

Study ID: NCT02595957

Sponsor

National Human Genome Research Institute (NHGRI)

Collecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders

Study ID: NCT00830557

Sponsor

Mayo Clinic

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

Study ID: NCT02910557

Sponsor

Amgen

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Study ID: NCT04239157

Sponsor

M.D. Anderson Cancer Center

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Study ID: NCT06909357

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

IDOV-Immune for Advanced Solid Tumors

Study ID: NCT06910657

Sponsor

Viromissile, Inc.

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Study ID: NCT03784326

Sponsor

M.D. Anderson Cancer Center